Skip to main content
Clinical Trials/KCT0001385
KCT0001385
Recruiting
未知

Effect of a 12-week cognitive training on cognitive function and brain metabolism in patients with amnestic mild cognitive impairment

Dong-A University Hospital0 sites64 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Mental and behavioral disorders
Sponsor
Dong-A University Hospital
Enrollment
64
Status
Recruiting
Last Updated
7 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
7 years ago
Study Type
Interventional Study
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. memory complaint corroborated by a participant and an informant
  • 2\. delayed recall score on the Seoul Verbal Learning Test (SVLT) at or below \-1 standard deviations from the mean of the age and education\-normative values among the Korean population
  • 3\. Global CDR(Clinical Dementia Rating) score is 0\.5, Memory CDR(Clinical Dementia Rating) score is 0\.5 or 1\.
  • 4\. normal functional activities. S\-IADL score :0\-7
  • 5\. Not diagnosed with dementia
  • 6\. Modified Hachinski Ischemic Score (HIS): 0\-4
  • 7\. He/She can read and write
  • 8\. 50 to 85 years of age
  • 9\. brain magnetic resonance imaging or CT showing no clinical evidence of other diseases (i.e., normal pressure hydrocephalus, brain tumor, cerebrovascular disease) capable of producing cognitive impairment.
  • 10\. written informed consent

Exclusion Criteria

  • 1\. any patient who were involved in other clinical trials or treated with experimental drug within 4 weeks
  • 2\. any patients with any severe or unstable medical disease that may prevent the patient from completing all study requirements (i.e., unstable or severe asthma or cardiovascular disease, active gastric ulcer, severe hepatic or renal disease)
  • 3\. any patients with clinically significant laboratory abnormalities such as an abnormal thyroid function test, abnormal low level of vitamin B12 or folate, or positive venereal disease research laboratory test
  • 4\. ny patients with any primary neurodegenerative disorder or psychiatric disorder other than AD (i.e., Parkinson's disease, schizophrenia, or major depressive disorder)
  • 5\. any patiens with any history of drug or alcohol addiction during the past 10 years
  • 6\. any hearing or visual impairment that can disturb the efficient evaluation of the patient

Outcomes

Primary Outcomes

Not specified

Similar Trials